試題詳解

4. 生物製劑(biologicals)之研發成功,使得類風濕性關節炎之治療有長足之進步.請問下列之生物製劑及作用機制之配對中，那一項是錯誤？
(A) adalimumab : TNF-alpha inhibition
(B) abatacept : T cell costimulation blockage
(C) etanercept : TNF-alpha inhibition
(D) rituximab : B cell depletion
(E) tocilizumab : IL-1 inhibition